Unknown

Dataset Information

0

CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases.

ABSTRACT:

SUBMITTER: Ilyas R 

PROVIDER: S-EPMC9935849 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases.

Ilyas Rimal R   McCullough Kristen K   Badar Talha T   Patnaik Mrinal M MM   Alkhateeb Hassan H   Mangaonkar Abhishek A   Pardanani Animesh A   Tefferi Ayalew A   Gangat Naseema N  

Blood cancer journal 20230217 1

Similar Datasets

Unknown Renal biopsy cases in myeloproliferative neoplasms (MPN).
| S-EPMC5411553 | biostudies-literature
Unknown Effects of calreticulin deficiency and myeloproliferative neoplasm (MPN)-linked mutation on cellular calcium signaling.
| S-EPMC12262281 | biostudies-literature
Unknown Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
| S-EPMC9538387 | biostudies-literature
Unknown Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells.
| S-EPMC8803998 | biostudies-literature
Unknown Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase.
| S-EPMC9089790 | biostudies-literature
Unknown Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts.
| S-EPMC5940634 | biostudies-literature
Unknown Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN).
| S-EPMC8307561 | biostudies-literature
Transcriptomics Genomic_analysis_of_408_myeloproliferative neoplasm(MPN)_samples
2011-07-01 | E-MTAB-608 | biostudies-arrayexpress
Unknown Role of Next Generation Immune Checkpoint Inhibitor (ICI) Therapy in Philadelphia Negative Classic Myeloproliferative Neoplasm (MPN): Review of the Literature.
| S-EPMC10420159 | biostudies-literature
Unknown CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies.
| S-EPMC8791570 | biostudies-literature